Linda E. Keyes

Linda E. Keyes

Auto-generated profile, based on publicly available information

Linda E. Keyes

University of Colorado

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2024 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
HGHannes Gatterer
Hannes Gatterer
FVFrancisco C. Villafuerte
Francisco C. Villafuerte
SUSilvia Ulrich
Silvia Ulrich
SBSanjeeb S. Bhandari
Sanjeeb S. Bhandari
LKLinda E. Keyes
Linda E. Keyes
Martin BurtscherMartin Burtscher
Martin Burtscher

1 June 2024 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
LGLaurel Gardner
Laurel Gardner
LKLinda E. Keyes
Linda E. Keyes
CPCaleb Phillips
Caleb Phillips
ESElan Small
Elan Small
TATejaswi Adhikari
Tejaswi Adhikari
JMJames Marvel
James Marvel
Gardner, Laurel, Linda E. Keyes, Caleb Phillips, Elan Small, Tejaswi Adhikari, Nathan Barott, Ken Zafren, Rony Maharjan, and James Marvel. Women at altitude: Menstrual-cycle phase, menopause, and exogenous progesterone are not associated with acute mountain sickness. High Alt Med Biol. 00:000–000, 2024. Background: Elevated progesterone levels in women may protect against acute mountain sickness (AMS). The impact of hormonal contraception (HC) on AMS is unknown. We examined the effect of natural and exogenous progesterone on the occurrence of AMS. Methods: We conducted a prospective observational convenience study of female trekkers in Lobuche (4,940 m) and Manang (3,519 m). We collected data on last menstrual period, use of exogenous hormones, and development of AMS. Results: There were 1,161 trekkers who met inclusion criteria, of whom 307 (26%) had AMS. There was no significant difference in occurrence of AMS between women in the follicular (28%) and the luteal (25%) phases of menstruation (p = 0.48). The proportion of premenopausal (25%) versus postmenopausal women (30%) with AMS did not differ (p = 0.33). The use of HC did not influence the occurrence of AMS (HC 23% vs. no HC 26%, p = 0.47), nor did hormonal replacement therapy (HRT) (HRT 11% vs. no HRT 31%, p = 0.13). Conclusion: We found no relationship between menstrual-cycle phase, menopausal status, or use of exogenous progesterone and the occurrence of AMS in trekkers and conclude that hormonal status is not a risk factor for AMS. Furthermore, women should not be excluded from future AMS studies based on hormonal status.

1 December 2024 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
LHLenka Horakova
Lenka Horakova
SKSusi Kriemler
Susi Kriemler
VŠVladimír Študent
Vladimír Študent
JHJacqueline Pichler Hefti
Jacqueline Pichler Hefti
DHDavid Hillebrandt
David Hillebrandt
LKLinda E. Keyes
Linda E. Keyes
Horakova, Lenka , Susi Kriemler, Vladimír Študent, Jacqueline Pichler Hefti, David Hillebrandt, Dominique Jean, Kastė Mateikaitė-Pipirienė, Peter Paal, Alison Rosier, Marija Andjelkovic, Beth Beidl...

27 October 2025 in Wilderness & Environmental Medicine
Verified
Journal Article
Closed access
DLDanielle Lee
Danielle Lee
SSShyamala Subramanian
Shyamala Subramanian
LKLinda E. Keyes
Linda E. Keyes
ZPZiva Petrin
Ziva Petrin
Introduction: Although rock climbing is approaching gender parity in participation, female representation in rock climbing research remains to be investigated. We evaluated the gender distribution of study participants and authorship in the rock climbing literature. Methods: We conducted a systematic review with PubMed and Embase to identify original research articles involving rock climbers. We categorized articles by and extracted data on the sex (female and male) of study participants and authors. Author gender was classified with Genderize.io, an automated probability-based assessment software. Results: We identified 298 original research articles from 1973 to 2023. Among the 266 articles that reported study participant gender, females comprised 36% of climber participants. Eighty-two articles (31%) had all-male climber participants, whereas 7 articles (3%) had an all-female cohort. Female climbers were the most underrepresented in articles investigating chronic climbing injuries (13% female), imaging studies (15%), and injury rehabilitation (20%). Female representation was highest in studies about youth climbing (43%) and epidemiology (36%). Of 1360 total authorships, 290 (21%) were female. Females were first authors for 54 articles (18%) and last authors for 53 articles (18%). Articles with female first authors had a higher proportion of female study participants than those with male first authors (39 vs 36%; P <0.001), whereas the proportion was similar between female and male last authors (36 vs 36%; P =0.592). Conclusions: Female representation in climbing research and authorship is limited. Most research has studied male climbers, limiting the ability to apply these results to female climbers.

7 November 2025 in Wilderness & Environmental Medicine
Verified
Journal Article
Closed access
CCChristanne Coffey
Christanne Coffey
VDValerie Dobiesz
Valerie Dobiesz
LKLinda E. Keyes
Linda E. Keyes
SSSarah Schlein
Sarah Schlein

1 December 2025 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
MHMatthias P. Hilty
Matthias P. Hilty
UHUrs Hefti
Urs Hefti
PBPierre Bouzat
Pierre Bouzat
HGHannes Gatterer
Hannes Gatterer
LHLenka Horakova
Lenka Horakova
BCBenoit Champigneulle
Benoit Champigneulle
Hilty, Matthias P., Urs Hefti, Pierre Bouzat, Hannes Gatterer, Lenka Horakova, Linda E. Keyes, Justin Lawley, Benjamin D. Levine, George Rodway, Daniel Trevena, Eduardo Vinhaes, and Benoit Champigneulle. Xenon inhalation for expeditions to high altitude: A position statement from the International Climbing and Mountaineering Federation (Union Internationale des Associations d’Alpinisme, UIAA) Medical Commission. High Alt Med Biol. 26:385–387, 2025. Background and Methods: Recently, xenon inhalation has been advertised for use as a pre-acclimatization method for high-altitude climbs, but this use is controversial and not without risks. The International Climbing and Mountaineering Federation ( Union Internationale des Associations d’Alpinisme , UIAA) Medical Commission convened a panel, including external experts, to develop a position statement on xenon inhalation as a pre-acclimatization method. Results: In this statement, we summarize the current state of research and discuss possible directions of future investigations. A pre-acclimatization strategy using xenon inhalation includes risks of respiratory depression, hypoxemia, systemic hypertension, and neurological impairment. The potential benefits of xenon inhalation, such as erythropoiesis, an increase in hemoglobin mass, or increased oxygen availability to the tissues, are not supported by the existing, current evidence. Conclusion: The UIAA Medical Commission recommends against the use of xenon inhalation in preparation for or during expeditions to high altitude unless part of a controlled study with appropriately qualified medical support such as anesthesia personnel.